Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Targeted Drug Delivery Partnering Deal Trends, Players, Financials and Forecasts 2012-2018 -

Research and Markets
Posted on: 22 Mar 18

The "Global Targeted Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts" report has been added to's offering.

Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world's leading healthcare companies. This report provides details of the latest Targeted Drug Delivery agreements announced in the life sciences since 2012.

The report takes the reader through a comprehensive review Targeted Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Targeted Drug Delivery partnering deals.

The report presents financial deal term values for Targeted Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

One of the key highlights of the report is that over 160 online deal records of actual Targeted Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Targeted Drug Delivery technologies and products.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Targeted Drug Delivery dealmaking

Chapter 3 - Leading Targeted Drug Delivery deals

Chapter 4 - Most active Targeted Drug Delivery dealmakers

Chapter 5 - Targeted Drug Delivery contracts dealmaking directory

Chapter 6 - Targeted Drug Delivery dealmaking by technology type

Chapter 7 - Partnering resource center

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.